FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer
Marme, F., Werft, W., Benner, A., Burwinkel, B., Sinn, P., Sohn, C., Lichter, P., Hahn, M., Schneeweiss, A.Volume:
21
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdq017
Date:
August, 2010
File:
PDF, 133 KB
english, 2010